The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 60 | — | 20.1x | Near average | |
Growth | 23 | — | 5.6% | Below average | |
Quality | 11 | -67.3% | 7.6% | Below average | |
Safety | 46 | -0.1x | 0.4x | Near average | |
Capital Return | 37 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Alpha Tau Medical Ltd. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Alpha Tau Medical Ltd. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Analysts' outlook for DRTS has seen a positive shift over the past 30 days, with the average target price increasing by 10.17% to reach $12.67. This rise is primarily driven by a new analyst (Barclays) initiating coverage with an 'Overweight' rating, bringing the number of analysts tracking the target price to two. There is a notable Dispersion between the $8 low and $15 high, reflecting uncertainty regarding the speed of achieving returns despite general optimism.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.